Background illustration for clinical trials search

Paid Clinical Trials Utah

Discover 1,094 paid clinical trials in Utah. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1
Active & Responsive

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

for
Macular Degeneration, Age-Related Macular Degeneration,
Location: Hauppauge NY, Cherry Hill NJ, Bethlehem PA,
Sponsor: EyeBiotech Ltd.

Sex: All

Age: 50+

Code: NCT07440225

Phase2, Phase3, Recruiting
Active & Responsive

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

for
Solid Tumor Malignancies, Colorectal Carcinoma,
Location: Philadelphia PA, Fairfax VA, Orlando FL,
Sponsor: Tasca Therapeutics

Sex: All

Age: 18+

Code: NCT07030257

Phase1, Phase2, Recruiting
Active & Responsive

Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer

for
Prostate Cancer, Metastatic Prostate Cancer,
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: Male

Age: 21+

Code: NCT07032584

Recruiting
Active & Responsive

Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)

for
Optic Neuritis, Myelitis, Myelitis, Transverse
Location: Boston MA, North Haven CT, New York NY, Baltimore MD,
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT07100990

Phase3, Recruiting
Active & Responsive

A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy

for
Kidney Disease
Location: East Providence RI, Philadelphia PA, Media PA,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT06963827

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)

for
Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
Location: New York NY, Philadelphia PA, Washington D.C. DC,
Sponsor: Electra Therapeutics Inc.

Sex: All

Age: 6+

Code: NCT05416307

Phase2, Phase3, Recruiting
Active & Responsive

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

for
Atherosclerotic Cardiovascular Disease (ASCVD)
Location: Summit NJ, Bowie MD, Ft. Washington MD, Falls Church VA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT06813911

Phase3, Recruiting
Active & Responsive

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

for
Glioma, Astrocytoma, Grade IV, IDH1-mutant Glioma,
Location: Boston MA, New Haven CT, New York NY, New Brunswick NJ,
Sponsor: Nuvation Bio Inc.

Sex: All

Age: 18+

Code: NCT05303519

Phase3, Recruiting
Active & Responsive

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

for
PIK3CA Mutation, HER2- Negative Breast Cancer,
Location: Boston MA, New Haven CT, New York NY, Hackensack NJ,
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06982521

Phase3, Recruiting
Active & Responsive

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

for
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer,
Location: Boston MA, Providence RI, Worcester MA, Hartford CT,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT06901531

Phase3, Recruiting
Active & Responsive

A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome

for
Dravet Syndrome
Location: Boston MA, New York NY, Washington D.C. DC,
Sponsor: Stoke Therapeutics, Inc

Sex: All

Age: 2 - 17

Code: NCT06872125

Phase3, Recruiting
Active & Responsive

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

for
Breast Cancer, Endometrial Cancer, Ovarian Cancer,
Location: Boston MA, Fairfax VA, Orlando FL, Huntersville NC,
Sponsor: Terremoto Biosciences Inc.

Sex: All

Age: 18+

Code: NCT07109726

Phase1, Phase2, Recruiting
Active & Responsive

TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II

for
Lymphoblastic Leukemia
Location: New York NY, Norfolk VA, Hershey PA, Orlando FL,
Sponsor: Tanja Andrea Gruber

Sex: All

Age: 0 - 1

Code: NCT05848687

Phase1, Phase2, Recruiting
Active & Responsive

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

for
Advanced Melanoma
Location: Boston MA, Lake Success NY, New York NY,
Sponsor: Immunocore Ltd

Sex: All

Age: 18+

Code: NCT05549297

Phase3, Recruiting
Active & Responsive

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

for
Ulcerative Colitis
Location: Providence RI, New York NY, Montreal, Chevy Chase MD,
Sponsor: Takeda

Sex: All

Age: 18 - 65

Code: NCT06095128

Recruiting
Active & Responsive

Evaluation of Outcomes Following In-office Tympanostomy Using the Tula® System: a Prospective, Multi-center Registry

for
Otitis Media With Effusion, Acute Otitis Media, Otitis Media
Location: New York NY, New Brunswick NJ, Cherry Hill NJ,
Sponsor: Smith & Nephew, Inc.

Sex: All

Age: 0 - 17

Code: NCT05915078

Recruiting
Active & Responsive

Mechanisms of Rumination Change in Adolescent Depression

for
Major Depressive Disorder, Mood Disorders
Location: Columbus OH, Salt Lake City UT
Sponsor: Ohio State University

Sex: All

Age: 14 - 17

Code: NCT03859297

Recruiting
Active & Responsive

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

for
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
Location: New Haven CT, New York NY, Philadelphia PA,
Sponsor: Duke University

Sex: All

Age: 21+

Code: NCT01915511

Recruiting
Active & Responsive

Fontan Udenafil Exercise Longitudinal Assessment Trial - 2

for
Single Ventricle Heart Disease
Location: Boston MA, New Haven CT, New York NY, Philadelphia PA,
Sponsor: Mezzion Pharma Co. Ltd

Sex: All

Age: 12 - 18

Code: NCT05918211

Phase3, Recruiting
Active & Responsive

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

for
Head and Neck Carcinoma, Adenoid Cystic Carcinoma, Lung Cancer,
Location: Hartford CT, New York NY, Englewood NJ, Florham Park NJ,
Sponsor: VM Oncology, LLC

Sex: All

Age: 18 - 70+

Code: NCT03556228

Phase1, Phase2, Recruiting

Popular cities in Utah

Offering a robust healthcare network and esteemed research institutions, Utah is a significant hub for clinical trials. Leading centers like the University of Utah Health, Huntsman Cancer Institute, and the Intermountain Healthcare system are at the forefront of medical research and innovation. Utah's strong emphasis on research and its collaborative environment make it a prominent state for conducting impactful clinical trials.

Why choose Utah for clinical trials?

Utah offers distinct advantages for those participating in clinical trials. The state's diverse population, combined with its strong emphasis on community health and wellness, enriches the research landscape with a wide range of participants. Utah is also recognized for its innovative research environment, with a notable focus on advancing medical science and exploring cutting-edge treatments, particularly in pediatrics.

Choosing to participate in a clinical trial in Utah means contributing to crucial medical research while benefiting from a supportive and well-established clinical research system. Utah’s commitment to excellence in research, along with its collaborative approach and advanced facilities, makes it an excellent choice for those looking to engage in meaningful and impactful studies.

Common conditions studied in Utah

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Utah